Pfizer Pharma GmbH secures contract for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to * 130a Abs 8 SGB V for the active ingredient tofacitinib, ATC L04AA29 for the time 01092023 - 31082025

Germany, Sept. 1 -- Germany based Pfizer Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to * 130a Abs 8 SGB V for the active ingredient tofacitinib, ATC L04AA29 for the time 01092023 - 31082025. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....